Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Depreciation and Depletion (2020 - 2025)

Historic Depreciation and Depletion for Celularity (CELU) over the last 5 years, with Q3 2025 value amounting to $1.4 million.

  • Celularity's Depreciation and Depletion fell 467.41% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year decrease of 835.93%. This contributed to the annual value of $6.2 million for FY2024, which is 1349.04% down from last year.
  • According to the latest figures from Q3 2025, Celularity's Depreciation and Depletion is $1.4 million, which was down 467.41% from $1.5 million recorded in Q2 2025.
  • Celularity's Depreciation and Depletion's 5-year high stood at $2.1 million during Q4 2021, with a 5-year trough of $1.4 million in Q1 2021.
  • Over the past 4 years, Celularity's median Depreciation and Depletion value was $1.5 million (recorded in 2024), while the average stood at $1.6 million.
  • In the last 5 years, Celularity's Depreciation and Depletion surged by 6021.84% in 2021 and then crashed by 894.41% in 2025.
  • Quarter analysis of 4 years shows Celularity's Depreciation and Depletion stood at $2.1 million in 2021, then fell by 15.14% to $1.7 million in 2022, then fell by 13.94% to $1.5 million in 2024, then dropped by 3.47% to $1.4 million in 2025.
  • Its Depreciation and Depletion stands at $1.4 million for Q3 2025, versus $1.5 million for Q2 2025 and $1.5 million for Q1 2025.